While αβ T cells primarily recognize the antigens presented by major histocompatibility complex (MHC) molecules [3], Vγ9Vδ2 T cells generally identify tumors without MHC, often via butyrophilin (BTN) complexes on tumor cell surfaces [4]. This evidence concerns the gene HLA-C and neoplasm.